Alemtuzumab 1 of 5
Our research 2 of 5
Our people 3 of 5
For people with MS 4 of 5- The CCMR One trial 5 of 5
Welcome
Thank you for taking an interest in our work. We hope that you can find what we are looking for, whether you are a colleague scientist, a patient with neurological disease or generally interested. Please do not hesitate to contact us directly.
Featured News
MS Society Press Release on the bexarotene trial
Trial shows myelin repair in humans is possible Friday 25 September 2020 The results from our Phase 2a clinical trial have shown…
News from our work experience students
We have just [August 2020] recieved these emails from two students who did work experience with us last year: “I…
Association of British Neurologists advice on DMT use during COVID
Advice on the use of disease modifying therapies during the COVID pandemic has been issued by the Association of British…